Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
AVADEL PHARMACEUTICALS PLC (AVDL)
|
|
Operating Efficiency |
|
|
|
|
Annual |
|
In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| Source | Source | Source | Source | Source | Source | Source | Source |
Turnover Ratios |
Inventory turnover | | 3.2 | 2.9 | 3.2 | 3.5 | 3.8 | 2.2 | 0.7 |
Asset turnover | 0.0 | 0.1 | 0.3 | 0.5 | 0.7 | 0.7 | 0.9 | 0.1 |
|
Returns on Capital |
ROIC (excluding intangibles) | -38.1% | 33.9% | -21.3% | -63.5% | 62.0% | 210.5% | 114.8% | -138.1% |
ROIC (including intangibles) | -39.9% | 22.2% | -21.0% | -36.2% | 29.7% | 128.9% | 50.4% | -52.8% |
ROE | -90.8% | 31.2% | 76.5% | -1864.7% | 52.5% | 447.5% | 79.1% | -144.2% |
ROA | -28.7% | 16.2% | -14.8% | -27.2% | 17.7% | 76.7% | 25.4% | -20.6% |
|
Cash Conversion Cycle |
Days sales outstanding | | 0.0 | 51.0 | 40.0 | 31.1 | 43.3 | 15.8 | 40.9 |
Days payables outstanding | -52,883.7 | 186.5 | 183.6 | 73.0 | 167.4 | 195.8 | 161.5 | 865.7 |
Days inventory outstanding | | | 107.5 | 99.4 | 137.9 | 89.8 | 117.3 | 726.0 |
Cash conversion cycle | | -186.5 | -25.1 | 66.4 | 1.6 | -62.7 | -28.4 | -98.8 |
|